Medline ® Abstract for Reference 64
of 'Overview of the use of estrogen-progestin contraceptives'
64
TI
End of the line for "third-generation-pill" controversy?
AU
Vandenbroucke JP, Rosendaal FR
SO
Lancet. 1997;349(9059):1113.
AD
Department of Clinical Epidemiology, Leiden University Hospital, The Netherlands.
PMID